Neurodegeneration in multiple sclerosis: Defining the problem Neurodegeneration in multiple sclerosis: Defining the problem2018-01-17T17:05:18-05:00
Neurodegeneration, neuroprotection, glial cells, and myelin in multiple sclerosis Neurodegeneration, neuroprotection, glial cells, and myelin in multiple sclerosis2018-01-17T17:05:18-05:00
A mighty mouse: building a better model of multiple sclerosis A mighty mouse: building a better model of multiple sclerosis2018-01-17T17:05:11-05:00
Neurodegeneration and –protection in autoimmune CNS inflammation Neurodegeneration and –protection in autoimmune CNS inflammation2018-01-17T17:05:05-05:00
Pathogenesis of axonal and neuronal damage in multiple sclerosis Pathogenesis of axonal and neuronal damage in multiple sclerosis2018-01-17T17:04:58-05:00
Dysfunction of the blood-brain barrier in the pathogenesis of MS Dysfunction of the blood-brain barrier in the pathogenesis of MS2018-01-17T17:04:58-05:00
Dual role of inflammation in CNS disease Dual role of inflammation in CNS disease2018-01-17T17:04:58-05:00
Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients2018-01-17T17:04:40-05:00
